Allergy and Immunology · Homewood, AL
NPI
1154543452
Since 2007
Specialty
Allergy and Immunology
Code 207K00000X
Group practices
3
Medicare group memberships
Hospitals
1
Hospital affiliations
504 Brookwood Blvd
Homewood, AL, 35209
Phone (205) 871-9661
Groups this clinician bills Medicare through
Medicare paid, 2024
$427K
17,581 services
Medicare patients, 2024
188
Average age 71
Drug cost, 2024
$9.0M
2,687 prescriptions
Company payments, 2025
$120K
From 24 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by John T Anderson was code J2357 (injection, omalizumab, 5 mg), 8,430 times for 17 patients. In total John T Anderson billed 17,581 services in 45 codes, and Medicare paid $427K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-03-11.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J2357 Injection, omalizumab, 5 mg | Office | 8,430 | 17 | $29.88 | $252K |
| 95004 Test - Miscellaneous | Office | 1,365 | 28 | $2.25 | $3,065 |
| 95044 Test - Miscellaneous | Office | 754 | 12 | $3.24 | $2,445 |
| 95165 Treatment - Miscellaneous | Office | 312 | 16 | $9.43 | $2,942 |
| 96401 Chemotherapy Administration | Office | 271 | 25 | $49.06 | $13K |
| 99214 Office E&M - Established | Office | 190 | 122 | $81.25 | $15K |
| 95117 Treatment - Miscellaneous | Office | 115 | 17 | $6.65 | $765 |
| 96372 Injection Administration | Office | 68 | 17 | $7.04 | $479 |
| 94010 Pulmonary Function Testing | Office | 62 | 41 | $17.62 | $1,092 |
| 99204 Office E&M - New | Office | 46 | 46 | $98.45 | $4,529 |
| 96160 E&M - Miscellaneous | Office | 41 | 32 | $1.99 | $81.48 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 20 | 20 | $12.09 | $242 |
| 95012 Pulmonary | Office | 15 | 15 | $11.08 | $166 |
| 99215 Office E&M - Established | Office | 12 | 11 | $105.27 | $1,263 |
By year: 2022 $445K for 13,303 services; 2023 $520K for 16,267 services; 2024 $427K for 17,581 services.
Medicare prescription drug claims, 2024
In 2024, the drug John T Anderson prescribed most often to Medicare patients was Montelukast Sodium, with 240 prescriptions and refills. In total John T Anderson wrote 2,687 Medicare prescriptions that cost $9.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Montelukast Sodium Generic | 240 | 413 | 59 | $3,110 |
| Azelastine Hcl Generic | 203 | 290 | 77 | $6,293 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 187 | 202 | 75 | $4,879 |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 127 | 143 | 29 | $90K |
| Prednisone Generic | 104 | 105 | 68 | $243 |
| Xolair Omalizumab | 103 | 103 | 12 | $286K |
| Takhzyro Lanadelumab-Flyo | 89 | 89 | Under 11 | $4.4M |
| Epinephrine Generic | 88 | 88 | 79 | $19K |
| Dupixent Pen Dupilumab | 84 | 84 | 11 | $307K |
| Fluticasone Propionate Generic | 81 | 123 | 24 | $1,159 |
| Icatibant Icatibant Acetate | 75 | 75 | 15 | $1.3M |
| Levocetirizine Dihydrochloride Generic | 73 | 106 | 17 | $696 |
| Breo Ellipta Fluticasone/Vilanterol | 65 | 79 | 13 | $31K |
| Azithromycin Generic | 65 | 68 | 25 | $864 |
| Dulera Mometasone/Formoterol | 53 | 59 | 11 | $19K |
Brand drugs: 1,197 claims; generic drugs: 1,476 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid John T Anderson $120K ($120K in general payments such as food, travel and fees) from 24 companies. The largest payer was CSL Behring with $43K.
| Company | Payments | Amount |
|---|---|---|
| CSL Behring CSL.AX | 56 | $43K |
| Pharming Healthcare, Inc. | 23 | $28K |
| Ionis Pharmaceuticals, Inc. IONS | 15 | $12K |
| Sanofi US Services Inc. SNY | 9 | $11K |
| BioCryst Pharmaceuticals, Inc. BCRX | 10 | $7,750 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 10 | $6,734 |
| GlaxoSmithKline, LLC. GSK | 11 | $5,571 |
| Blueprint Medicines Corporation SNY | 9 | $3,285 |
| BioCryst US Sales Co., LLC | 10 | $413 |
| Novartis Pharmaceuticals Corporation NVS | 10 | $297 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.